Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers
Clinical trial NCT05041257 · COMPLETED
Trial details
- NCT number
- NCT05041257
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-19
- Primary completion
- 2024-12-12
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.